Improvement of schizophrenic symptoms and changes in plasma HVA concentrations, plasma anti-D2 and anti-5-HT2 receptor activities with clozapine

MLA

Masahiro Asai, et al. “Improvement of Schizophrenic Symptoms and Changes in Plasma HVA Concentrations, Plasma Anti-D2 and Anti-5-HT2 Receptor Activities with Clozapine.” Psychiatry and Clinical Neurosciences, vol. 50, no. 5, Oct. 1996. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a041236c2863a64629a7f3e70472bb91&authtype=sso&custid=ns315887.

APA

Masahiro Asai, Masashi Nibuya, Eiji Suzuki, Fang Yi‐Yu, Yan He‐Gin, Wang Zu‐Cheng, Gohei Yagi, Kazuo Yamada, & Shigenobu Kanba. (1996). Improvement of schizophrenic symptoms and changes in plasma HVA concentrations, plasma anti-D2 and anti-5-HT2 receptor activities with clozapine. Psychiatry and Clinical Neurosciences, 50(5).

Chicago

Masahiro Asai, Masashi Nibuya, Eiji Suzuki, Fang Yi‐Yu, Yan He‐Gin, Wang Zu‐Cheng, Gohei Yagi, Kazuo Yamada, and Shigenobu Kanba. 1996. “Improvement of Schizophrenic Symptoms and Changes in Plasma HVA Concentrations, Plasma Anti-D2 and Anti-5-HT2 Receptor Activities with Clozapine.” Psychiatry and Clinical Neurosciences 50 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a041236c2863a64629a7f3e70472bb91&authtype=sso&custid=ns315887.